The present invention relates to methods and compositions for modulating the control of apoptosis, specifically for modulating the interaction between hnRNP-K and lincRNA-p21 to induce or prevent apoptosis in the cell.
This nanotech reagent significantly enhances detection sensitivity and signal consistency in POC diagnostics. Its superior performance stems from a specialised synthesis method and proprietary know-how. This expertise is essential for the reagent’s successful reproduction, formulation, and